The FDA and Canada's drug regulating body announced Thursday that popular heartburn drugs Prilosec and Nexium don't seem to pose heart risk, following a preliminary review. The agency found two small studies that suggested a concern were skewed and examined 14 other studies that showed no evidence of heart risk. The probe will be completed within three months.

Full Story:

Related Summaries